XML 73 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements (Tables)
3 Months Ended
Dec. 28, 2019
Fair Value Disclosures [Abstract]  
Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of December 28, 2019 (in thousands): 
Level 1Level 2Level 3Total
Liabilities:
Liability for contingent consideration (a)$—  $—  $1,323  $1,323  
Total liabilities$—  $—  $1,323  $1,323  
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of December 29, 2018 (in thousands): 
Level 1Level 2Level 3Total
Liabilities:
Liability for contingent consideration (a)$—  $—  $7,616  $7,616  
Total liabilities$—  $—  $7,616  $7,616  
The following table presents our financial assets and liabilities at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of September 28, 2019: 
Level 1Level 2Level 3Total
Liabilities:
Liability for contingent consideration (a)$—  $—  $7,369  $7,369  
Total liabilities$—  $—  $7,369  $7,369  
 
(a)The liability for contingent consideration relates to an earn-out for B2E, acquired in December 2012, future performance-based contingent payments for Hydro-Organics Wholesale, Inc., acquired in October 2015 and future performance-based contingent payments for Segrest, Inc., acquired in October 2016. In December 2019, performance-based criteria associated with the $6 million contingent consideration liability related to Segrest, Inc. were met and accordingly, the entire amount was released out of an independent escrow account to the former owners as of December 28, 2019. The fair value of the estimated contingent consideration arrangement is
determined based on the Company’s evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. This is presented as part of long-term liabilities in the Company's consolidated balance sheets.
Summary of Changes in Fair Value of Level 3 Financial Instruments
The following table provides a summary of the changes in fair value of the Company's Level 3 financial instruments for the periods ended December 28, 2019 and December 29, 2018 (in thousands):
 Amount
Balance September 28, 2019$7,369  
Estimated contingent performance-based consideration established at the time of acquisition—  
Changes in the fair value of contingent performance-based payments established at the time of acquisition31  
Performance-based payments (6,077) 
Balance December 28, 2019$1,323  
 
 Amount
Balance September 29, 2018$8,224  
Estimated contingent performance-based consideration established at the time of acquisition—  
Changes in the fair value of contingent performance-based payments established at the time of acquisition(554) 
Performance-based payments(54) 
Balance December 29, 2018$7,616